Cite
HARVARD Citation
Hollebecque, A. et al. (2022). Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies. Cancer. 128 (17), pp. 3185-3195. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hollebecque, A. et al. (2022). Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies. Cancer. 128 (17), pp. 3185-3195. [Online].